Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
Conditions: COVID-19 Respiratory Infection; Aspergillosis Intervention: Drug: Posaconazole Sponsors: Medical University of Graz; Merck Sharp & Dohme Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2021 Category: Research Source Type: clinical trials
Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis
Conditions: Chronic Respiratory Disease; Chronic Pulmonary Aspergillosis Intervention: Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2021 Category: Research Source Type: clinical trials